ALMUJTAMA MEDICAL 9592 0.00% 30.28 0.00 Element List Explanation Introduction The Board of Directors of Almujtama Alraida Medical Co. is pleased to invite the esteemed shareholders of the Company to participate and vote in the Ordinary General Assembly Meeting (First Meeting), which is scheduled, God willing, to be held at 8:00 PM on Monday, 12 January 2026, corresponding to 23-07-1447H, via modern technological means. City and Location of the General Assembly's Meeting Company headquarters - Jeddah - Al-Muhammadiyah district (Via modern technology means) Hyperlink of the Meeting Location Click Here Date of the General Assembly's Meeting 2026-01-12 Corresponding to 1447-07-23 Time of the General Assembly's Meeting 20:00 Methodology of Convening the General Assembly's Meeting Via modern technology means Attendance Eligibility, Registration Eligibility, and Voting End The right to attend shall be for shareholders registered in the issuer's shareholders' register at the Depository Center at the end of the trading session preceding the general assembly meeting, in accordance with the rules and regulations. The right to register attendance at the general assembly meeting shall also expire at the time the general assembly meeting is held, and the right to vote on the general assembly items for those present shall expire when the counting committee completes the counting of votes. Quorum for Convening the General Assembly's Meeting The validity of this meeting requires the attendance of shareholders representing at least a quarter of the company's shares with voting rights. If the quorum required to hold this meeting is not available, the second meeting will be held one hour after the end of the period specified for holding the first meeting, and the second meeting will be valid regardless of the number of shares with voting rights represented in it, based on the text of Article No. (28) of the company's articles of association. General Assembly Meeting Agenda 1. Voting on the Board of Directors' resolution to appoint Mr. Hamad Hamdan Al-Sourayia as a member of the Board of Directors (independent), effective from his appointment date of 25/11/2025, to complete the Board's term until the end of the current cycle on 31/07/2026, succeeding the former member Mr. Abdulaziz Ahmed Abdul Latif Bin Dayel (independent). The CV is attached.
2. Voting on amending the Conflict of Interest Policy.
3. Voting on the Regulations and Criteria for Participating in Competing Businesses.
4. Voting on the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Shara'a District, with an annual value of (160,000) Riyals, excluding Value Added Tax (VAT) (15%), and a contract duration of (18) months starting from 07/03/2024. The value of transactions during the fiscal year 2024 amounted to (160,000) Riyals, excluding VAT (15%), along with a request to approve the renewal of the contract for 2025 for a period of one year until 06/09/2026. It is confirmed that all contract terms were agreed upon without granting any privileges or preferential conditions to any party.
5. Voting on the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Sanabel District, with an annual value of (550,000) Riyals, excluding Value Added Tax (VAT) (15%), for a period of ten years starting from 01/04/2023. The value of transactions during the fiscal year 2024 amounted to (550,000) Riyals, excluding VAT (15%), along with a request for authorization to continue the contract for the fiscal year 2025. It is noted that this contract was concluded without any preferential terms or advantages.
6. Voting on the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Ruhaily District, with an annual value of (400,000) Riyals, excluding Value Added Tax (VAT) (15%), for a period of 9 years and 11 months starting from 01/05/2023. The value of transactions during the fiscal year 2024 amounted to (400,000) Riyals, excluding VAT (15%), along with a request for authorization to continue the contract for the fiscal year 2025. It is noted that this contract was concluded without any preferential terms or advantages.
7. Voting on the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Marwah District, with an annual value of (420,000) Riyals, excluding Value Added Tax (VAT) (15%), for a period of ten years starting from 01/07/2024. The value of transactions during the fiscal year 2024 amounted to (210,000) Riyals, excluding VAT (15%), along with a request for authorization to continue the contract for the fiscal year 2025. It is noted that this contract was concluded without any preferential terms or advantages.
8. Voting on the transactions and contracts executed during 2024 that were concluded between the Company and Bright Screen Company (a single-person limited liability company owned by Mr. Mohammed Omar Khojah), wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah have an indirect interest. This pertains to a contract for the supply and installation of advertising screens for a total amount of (1,537,200) Riyals, excluding Value Added Tax (VAT) (15%). The value of transactions during the fiscal year 2024 amounted to (136,950) Riyals, excluding VAT (15%), along with a request for authorization to continue the supply for the fiscal year 2025. It is noted that this contract was concluded without preferential terms or advantages.
Proxy Form The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right Attending shareholders have the right to discuss the topics included in the General Assembly agenda, ask questions, and vote on them through the Tadawulati platform:
www.tadawulaty.com.sa
Details of the electronic voting on the Assembly's agenda Shareholders registered on the Tadawulaty electronic services website will be able to vote remotely on the Assembly's items through the (Electronic Voting) service. This service will commence at 1:00 AM on Thursday, 08-01-2026, corresponding to 19-07-1447H, and will continue until the conclusion of the Ordinary General Assembly meeting. Registration and voting on the Tadawulaty services will be available and free of charge for all shareholders using the following link:
WWW.TADAWULATY.COM.SA
Method of Communication in Case of Any Enquiries In the event of an inquiry about the association's terms, we hope to contact the Shareholder Relations Department, phone number 920008144, ext. 710, or email [email protected]. Attached Documents